13 Mar 2007
New York: Can Academia and Industry Work Hand-in-Glove? New York: Back to School—R and D in Academia New York: So Many Targets, So Little Time New York: Better Living Through Chemistry? New York: The Nose, Your Magic Portal? Drug Discovery for Neurodegene
13 Mar 2007
This week, two independent groups of academic researchers call for more transparency in the conduct of clinical trials...
13 Mar 2007
This is the final installment of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
12 Mar 2007
This is part 4 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
09 Mar 2007
This is part 3 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
09 Mar 2007
Peter Lorre’s Joel Cairo in <em>The Maltese Falcon</em> might have gotten it right with his gardenia-scented business card...
09 Mar 2007
Alzheimer disease brings on a tendency to wander, and patients sometimes become disoriented even in the most familiar surroundings...
08 Mar 2007
This is part 2 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
07 Mar 2007
This is part 1 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
07 Mar 2007
Synapses, those miniscule gaps across which neurons signal one another, are far from static...
06 Mar 2007
Myriad genetics presented additional 24-month data from the completed follow-on study of a phase 2 trial of its experimental Alzheimer drug...
05 Mar 2007
Boosting neuronal excitation with acetylcholinesterase inhibitors is one way of tackling cognitive decline in Alzheimer disease...
05 Mar 2007
Two papers last week addressed related puzzles in Huntington’s and related diseases, that is, why...
05 Mar 2007
Synaptic plasticity is a contest between long-term potentiation (LTP) and long-term depression (LTD), with the...
01 Mar 2007
Pat McCaffrey Interviews Randy Buckner